Concepta Ord 2.5p Share Price (CPT)

6.15 -0.20 (-3.15%) delayed: 1:00PM GMT
Bid price 6.00 Open price 6.11
Ask price 6.30 Prev close 6.35
High price 6.11 Spread 4.76%
Low price 6.06 Volume 140,000

Register now for FREE live Concepta Ord 2.5p share prices, Concepta Ord 2.5p stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Concepta Ord 2.5p Level 2 Data, indepth research tools and investor commentary for Concepta Ord 2.5p (CPT) and other London Stock Exchange equities.

Concepta Ord 2.5p Share Price Chart

Advanced Charts >>

Register now for FREE Concepta Ord 2.5p share price charts

Concepta Ord 2.5p Share Price Information

Name Concepta Ord 2.5p Epic CPT
Sector Health Care Equipment & Services ISIN GB00BYZ2R301
Activites Concepta plc (formerly Frontier Resources International plc) is a pioneering UK healthcare company that has developed a proprietary platform and products targeted at the personalised mobile health market with a primary focus on women's fertility and specifically unexplained infertility*. Founded in 2013, Concepta has developed a revolutionary flagship product 'MyLotus' for home self-testing that helps women with unexplained infertility to conceive. MyLotus is the only consumer product which allows both quantitative and qualitative measurements of measurement of a woman's personal hCG and LH hormone levels in an easy to use home test to facilitate higher conception rates and early diagnosis of any fertility problems. Competitor products currently only allow qualitative measurement and are based on the 'average woman'. Concepta has a defined route to market for its new 'My Lotus' product with Regulatory approvals for launch in China in place for 2016 and CE-Marking for UK and Europe to follow in 2018 where the revenue potential of the Chinese and EU infertility market is worth c.£600m per annum for the company. Index n/a

Concepta Ord 2.5p Key Numbers

Latest Share Price (p) 6.15 Net Gearing (%) -72.32
Market Capitalisation (£m) 8.78 Gross Gearing (%) 5.21
Shares in issue (m) 138.20 Debt Ratio 0.00
P/E Ratio -2.12 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.06
Dividend Yield (%) 0.00 Price to book value 2.65
Dividend cover (x) 0.00 ROCE (%) -77.34
Earning per share (p) -3.00 EPS Growth (%) -138.10
52 week high / low 19.00 / 5.65 DPS Growth (%) n/a

Concepta Ord 2.5p Director Deals

Dec.Date Type Director Pos No. of Shares
30/11/2017 BUY Erik Henau CEO 100,000
26/06/2017 BUY Erik Henau CEO 80,000
29/09/2008 BUY Patrick Cottrell RES 70,000

More Concepta Ord 2.5p Director Deals >>

Concepta Ord 2.5p Company News

07:00 20/02/2018

Launch of myLotus app in China

RNS Number : 3282F Concepta PLC 20 February 2018   20 February 2018   Concepta plc ("Concepta" or the "Company")   Launch of myLotus app in China   Concepta plc (AIM: CPT), the UK healthcare company and developer of a proprietary product targeted at...

09:04 16/02/2018

Concepta appoints David Darrock as COO

Concepta appointed David Darrock as Chief Operating Officer and Michelle Yao as China General Manager. Erik Henau, CEO of Concepta said: 'On behalf of the Board, I am delighted to announce these two senior appointments.' 'David joined Concepta in October 2017 as Site Director for our Doncaster...

07:00 16/02/2018

Two Senior Appointments and Grant of Options

RNS Number : 0722F Concepta PLC 16 February 2018   16 February 2018   Concepta plc ("Concepta" or the "Company")   Concepta Announces Two Senior Appointments and Grant of Options   Concepta plc (AIM: CPT) the UK healthcare company and developer of a...

More Concepta Ord 2.5p Company News >>

Register now for FREE Concepta Ord 2.5p company news

Concepta Ord 2.5p Share Price Discussions

4 months ago

MyLotus beginning to blossom (CPT)

Frontier Resources (AIM:FRI), agreed to acquire Concepta Diagnostics Limited (“Conceptaâ€), a pioneering UK healthcare company established in 2013, that has developed proprietary products and a platform, which targets the personalised mobile health market with a primary focus on women’s...

6 months ago

MyLotus beginning to blossom (CPT)

Frontier Resources (AIM:FRI), agreed to acquire Concepta Diagnostics Limited (“Conceptaâ€), a pioneering UK healthcare company established in 2013, that has developed proprietary products and a platform, which targets the personalised mobile health market with a primary focus on women’s...

Register now for FREE Concepta Ord 2.5p share price discussions